Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

News of the cancellation came as Moderna revealed positive interim data from a phase 1/2 trial of its pandemic influenza vaccine, mRNA-1018, which targets the H5N8 bird flu subtype as well as ...

As America grapples with one of the worst flu outbreaks in recent years, researchers are hoping to close in on a stronger ...

Allergies shots only mildly improved his ailment, and he must take medications to manage his symptoms. If he does not take medication in time, flu-like symptoms disrupt important work he’s doing ...